What determines the health-related quality of life among regional and rural breast cancer survivors? by Di Sipio, Tracey et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
QUT Digital Repository:  
http://eprints.qut.edu.au/ 
 
DiSipio, Tracey and Hayes, Sandi and Newman, Beth and Janda, Monika (2009) 
What determines the health-related quality of life among regional and rural 
breast cancer survivors? Australian and New Zealand Journal of Public Health, 
33(6). pp. 534-539. 
           
     ©  Copyright 2009 Public Health Association of Australia 
1 
Abstract 
Objective: To assess the health-related quality of life (HRQoL) of regional and rural breast 
cancer survivors at 12 months post-diagnosis and to identify correlates of HRQoL. 
Methods: 323 (202 regional and 121 rural) Queensland women diagnosed with unilateral 
breast cancer in 2006/2007 participated in a population-based, cross-sectional study. HRQoL 
was measured using the Functional Assessment of Cancer Therapy, Breast plus arm morbidity 
(FACT-B+4) self-administered questionnaire. 
Results: In age-adjusted analyses, mean HRQoL scores of regional breast cancer survivors 
were comparable to their rural counterparts 12 months post-diagnosis (122.9, 95% CI: 119.8, 
126.0 vs. 123.7, 95% CI: 119.7, 127.8; p>0.05). Irrespective of residence, younger (<50 
years) women reported lower HRQoL than older (50+ years) women (113.5, 95% CI: 109.3, 
117.8 vs. 128.2, 95%CI: 125.1, 131.2; p<0.05). Those women who received chemotherapy, 
reported two complications post-surgery, had poorer upper-body function than most, reported 
more stress, reduced coping, who were socially isolated, had no confidante for social-
emotional support, had unmet healthcare needs, and low health self-efficacy reported lower 
HRQoL scores. Together, these factors explained 66% of the variance in overall HRQoL. The 
pattern of results remained similar for younger and older age groups. 
Conclusions and Implications: The results underscore the importance of supporting and 
promoting regional and rural breast cancer programs that are designed to improve physical 
functioning, reduce stress and provide psychosocial support following diagnosis. Further, the 
information can be used by general practitioners and other allied health professionals for 
identifying women at risk of poorer HRQoL. 
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Introduction 
With advances in detection and treatment, increasing numbers of Australian women are 
diagnosed with, and surviving, breast cancer each year,1 making women with breast cancer 
one of the largest groups of cancer survivors. Unfortunately, treatment-related sequelae, such 
as pain, anxiety, and fatigue, can impede women returning to their normal activities following 
breast cancer, affecting women, their families, and the greater community. While concerns are 
short-lived for some, others struggle to regain their pre-cancer well-being. Hence, ensuring a 
good health-related quality of life (HRQoL) following treatment has become a focal point of 
cancer research and clinical interest. 
 
While our understanding regarding the impact of breast cancer on women’s well-being is 
improving, little is known about HRQoL among survivors in non-urban areas. This is 
important as 33% of new breast cancer cases in Australia live outside major metropolitan 
areas.2 Geographical variations are known to exist for many health outcomes, which are 
consistently worse in rural areas. For example, survival from breast cancer has been found to 
be highest among women living in major city and inner regional areas and lowest for women 
from outer regional and remote/very remote areas (five-year survival for women diagnosed in 
1997 was 86%, 86%, 83%, and 80%, respectively).3 Characteristics distinct to rural living that 
most likely contribute to differences in health outcomes may include socioeconomic 
disparities, environmental factors, access to health services, healthcare providers, screening 
and treatments,4 and access to oncology services requiring travel for treatment, placing 
additional demands on patients and their families. These same factors may contribute to 
poorer health among women following diagnosis and treatment for breast cancer. 
 
This study aimed to: 1) assess whether women residing in regional locations (and thus 
somewhat closer to health services) would report better HRQoL on average than women 
residing in rural locations of Queensland 12 months following breast cancer diagnosis; 2) 
assess factors that influence HRQoL; and 3) after adjusting for these factors, assess whether 
HRQoL reported by women residing in regional and rural areas would be similar. A 
secondary objective sought to explore to what extent age influenced the observed 
relationships. 
 
Methods 
Sample 
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Following ethical approval (Human Research Ethics Committee of the Queensland University 
of Technology), review (Queensland Cancer Registry (QCR) Advisory Committee), and 
legislative gazettal (Queensland Health), all women diagnosed with a first, primary, invasive, 
unilateral breast cancer between April 2006 and March 2007, aged 74 years or younger, 
residing in regional or rural areas of Queensland were identified from the QCR. The 
Accessibility/Remoteness Index of Australia (ARIA+) classification system (major city, inner 
regional, outer regional, remote, and very remote) was used to define place of residence.5 For 
this study, we defined residents of regional geographic regions as living in inner regional 
areas of Queensland, and rural residence as living in outer regional, remote or very remote 
areas. 
 
In accord with QCR protocols, written consent was obtained from notifying medical 
practitioners to contact 452/502 women (271 regional and 181 rural; 90.0%). Informed 
consent and a completed questionnaire then was obtained from 323/452 women (202 regional 
and 121 rural; 71.5%). 
 
Data collection 
Participants completed a mailed, self-administered questionnaire 12 months following 
diagnosis of breast cancer that obtained information on socio-demographic characteristics 
(e.g., age), cancer-related factors (e.g., adjuvant treatment, complications following surgery), 
general health (e.g., physical activity as measured with specific items from the Behavioural 
Risk Factor Surveillance System,6 upper-body function as measured by the Disabilities of 
Arm, Shoulder and Hand questionnaire,7 social networks as measured by the Social Networks 
Index8), healthcare service needs as measured by the Supportive Care Needs Survey – Access 
to Services module9, health efficacy as measured by the Self-Rated Abilities for Health 
Practices10 and HRQoL status. Pathology records were abstracted from the QCR to obtain 
breast cancer-specific information (e.g., type of surgery). 
 
HRQoL was measured using the Functional Assessment of Cancer Therapy, Breast plus arm 
morbidity (FACT-B+4) questionnaire, which is comprised of 40 items rated on a five-point 
Likert scale (ranging from 0 = not at all, to 4 = very much). The FACT-General (FACT-G) 
assesses four dimensions of HRQoL (physical, social, emotional, and functional well-being). 
The FACT-G score is calculated by summing the four general subscales; the FACT-B+4 also 
sums 13 questions relating to breast cancer concerns. Therefore, two overall summary scales 
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(FACT-B+4 and FACT-General) and five subscales (breast, physical, social, emotional, and 
functional well-being) were calculated as per the FACT manual,11 resulting in total scores 
ranging from 0-160 for the overall FACT-B+4, 0-108 for the overall FACT-G, 0-52 for the 
breast well-being subscale, 0-28 for the physical, social and functional well-being subscales, 
and 0-24 for the emotional well-being subscale. Higher scores represent better well-being. 
The FACT has excellent reliability and validity,12 has been  tested in a rural sample of cancer 
patients,13 and has been used previously to measure HRQoL among breast cancer survivors in 
Australia.14, 15 
 
Statistical analysis 
Chi-square tests were conducted to assess whether there were any group differences on 
categorical variables between the target sample and study participants, and between regional 
and rural breast cancer study participants. Where there were more than two categories, logistic 
regression was used to test for differences between categories. 
 
Distributions of the FACT-B+4 scores were approximately normal hence were summarised as 
means with 95% confidence intervals (CIs). Using SPSS (SPSS Inc, Chicago, IL, version 14), 
HRQoL scores for regional participants were compared to scores from rural participants by 
analysis of variance (ANOVA), adjusted for age. Pooled analyses were stratified by younger 
(<50 years) and older (50+ years) age to explore potential age-related differences in HRQoL. 
Statistical significance was defined as p<0.05, while a difference of eight or more points in 
mean FACT-B+4 scores was considered clinically meaningful.16 
 
To identify associations with HRQoL for regional and rural survivors separately, 
characteristics of interest were analysed with overall FACT-B+4 scores in one-way ANOVA 
tests, adjusted for age. As correlates of HRQoL were similar between the two geographic 
groups, regional and rural women were pooled in subsequent analyses and ‘place of 
residence’ was included as an independent variable. Formal tests of an interaction between 
residence and each of the characteristics of interest did not yield any statistically significant 
results. 
 
Overall FACT-B+4 scores were subjected to a series of age- and residence-adjusted multiple 
linear regression models for regional/rural survivors to identify the most important socio-
demographic, cancer-specific, general health, healthcare and health efficacy characteristics of 
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HRQoL. As per the scoring instructions for the Disabilities of Arm, Shoulder and Hand 
questionnaire (used to measure upper-body function),7 15 women did not complete sufficient 
items to be given a score. To avoid losing these women from the multivariable analysis, their 
upper-body function score was categorised as ‘missing’. Characteristics were included in a 
final model if they were either statistically significant or clinically meaningful as defined 
above. Underlying assumptions for this analytical technique were tested and met. 
 
Results 
Sample characteristics 
Demographic and disease characteristics were similar for the women in this study and those in 
the target sample, including age, residence, tumour and treatment characteristics (Table 1). 
Study sample characteristics are presented in Table 2. There were no significant differences 
between regional and rural study participants on the majority of socio-demographic 
characteristics, except a higher percentage of regional participants were retired or a student 
(24.3% versus 8.3%, p<0.01), and attained a moderate (grade 12, trade, TAFE, diploma) level 
of education (35.6% versus 24.8%, p=0.02) than rural participants. Regional and rural 
participants were also similar for most of the treatment, tumour, and general health 
characteristics. However, a higher percentage of rural women only received chemotherapy 
(15.7% versus 6.9%, p=0.01), and fewer rural women reported participating in a breast cancer 
program (20.7% versus 32.2%, p=0.03) compared with their regional counterparts. 
 
HRQoL scores at 12 months post-diagnosis 
In age-adjusted analyses, HRQoL summary and subscale scores among regional breast cancer 
survivors were comparable to rural survivors at 12 months post-diagnosis (Table 3). Breast 
well-being was the weakest subscale with participants reporting mean values at 71% on 
average of the maximum score, compared with approximately 80% of available points for all 
other subscales. As there was no difference in HRQoL, the regional and rural groups were 
pooled for age-stratified results. Younger (<50 years) women reported lower scores than older 
(50+ years) women for all scales (p<0.01 for each), although the difference for social well-
being lacked clinical importance. 
 
Associations with HRQoL 
Of the 323 women participating in this study, seven were excluded from multivariable 
analyses of the FACT-B+4 outcome due to missing data (n=316). After controlling for all 
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variables in the model (Table 4), rural breast cancer survivors reported slightly higher mean 
overall HRQoL scores than their regional counterparts, although the magnitude of the 
difference was neither clinically nor statistically significant (124.8 vs. 122.3, p=0.14). 
Differences in overall HRQoL scores by younger and older age group was attenuated when 
adjusted for characteristics in the model but remained statistically significant (120.3 vs. 124.7, 
p=0.03). 
 
Chemotherapy, upper-body function below the median, reporting more stress and poorer 
handling of stress, lack of a confidante, moderate to high need of healthcare services and 
poorer health self-efficacy emerged as important characteristics associated with lower 
HRQoL among regional/rural breast cancer survivors (Table 4). These characteristics were 
clinically meaningful and statistically significant correlates of HRQoL. Also, lack of social 
networks was clinically meaningful while reporting two complications was a statistically 
significant correlate. Together, these factors explained 66% of the variance in HRQoL. 
Similar trends were observed when the model was stratified by younger and older age groups, 
although means were consistently lower among younger women and higher among older 
women (data not shown). 
 
Discussion 
HRQoL was similar between regional and rural women who had been diagnosed with breast 
cancer 12 months prior. Irrespective of regional or rural residence, younger survivors reported 
lower HRQoL across all domains compared with their older counterparts. We found that in 
addition to age, lower HRQoL was observed among regional/rural breast cancer survivors 
who received chemotherapy, reported two complications following surgery, those with greater 
burdens (i.e., less than average upper-body function, high amounts of stress and poor handling 
of stress), who lacked social support (i.e., were socially isolated or had no confidante), those 
whose healthcare needs were not met, and women who felt less confident in relation to 
managing their health. These correlates were identified from adjusted analysis and therefore 
highlight the independent effects of each factor. The findings are consistent with 
characteristics identified previously in the literature when studied in isolation. Together, they 
explained two-thirds of the variance in HRQoL in this population-based sample of survivors 
residing in regional or rural Queensland. 
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Age-related differences observed among regional/rural survivors correspond with findings 
reported in the literature,17-19 and may be due to variations in the cancer or treatment received, 
and/or the responsibilities of women. To illustrate, in this study there were higher proportions 
of younger women who were diagnosed with a grade three tumour (46.7% versus 31.9%), 
and/or received chemotherapy and radiotherapy (66.4% versus 25.5%), compared with older 
women. Also, a higher proportion of older women reported three or more co-morbidities 
(68.5% versus 43.0%) compared with younger women. This is consistent with literature 
demonstrating that cancer is viewed as more aggressive in younger women who therefore 
receive more extensive treatment.18 More extensive treatment, such as receipt of adjuvant 
therapy, is associated with adverse effects, including lower HRQoL. In contrast, older women 
who have more co-morbid conditions may receive less aggressive treatment,17 or opt to trade 
HRQoL over survival.19 However, age-related differences in overall HRQoL in this study 
persisted, independent of treatment factors. 
 
Younger women in this study had more competing demands, such as child responsibilities 
(38.3% versus 2.3%) and work commitments (83.2% versus 63.7%), than older women. 
Consequently, age-related differences in HRQoL may reflect the point in the life cycle at 
which the cancer occurs, such that women’s roles as mothers, wives and career women are 
prematurely threatened. It has also been suggested that cancer is an anomalous event for 
younger people and, hence they may experience greater discordance between their health 
expectations and their current situation.20 These results reaffirm that younger women have 
more difficulty adjusting to the disease than older women. 
 
Tailored interventions to help mitigate the negative effects of treatment, and which consider 
the role of both physical (e.g., upper-body functioning) and emotional (e.g., stress and coping) 
aspects of recovery, may be required. Women may also benefit from age-appropriate recovery 
interventions, particularly psychological support for younger women and interventions that 
take into account the management of co-morbid conditions among older women. However, 
the services are frequently lacking in rural areas necessitating innovative models of service 
delivery. 
 
Breast care nurses are utilised in Brisbane, however, they are underemployed and 
underutilised in remote areas of Queensland.21 Breast cancer nurses could help patients to 
better navigate the healthcare system throughout treatment and monitor patients following 
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treatment, providing continuity of care specific to non-urban areas. For example, experienced 
nurses play a vital role in administering chemotherapy and in educating and supporting 
patients. General practitioners (GPs) also play a vital role in managing adverse effects of 
cancer treatment and providing appropriate referrals. Better communication between 
specialists and GPs can be beneficial to patients’ continued care.22 Better health care co-
ordination provided by a single provider is increasingly being adopted in the USA and has 
yielded positive effects on HRQoL among breast cancer survivors.23 
 
Another potential avenue for enhanced patient follow-up in rural areas is to expand the reach 
of currently available programs. For example, The Cancer Council’s program, Cancer 
Connect, is a one-to-one telephone support program that puts breast cancer patients in touch 
with a carefully-trained volunteer who has had similar treatment and similar family 
circumstances. The focus is on creating a social-emotional supportive network that is also 
age-appropriate.24 The Young Women’s Christian Association (YWCA) Encore program 
provides another avenue to assist with both psychosocial and physical issues of recovery. It 
offers a gentle exercise program, relaxation, meditation and companionship within small 
groups of women who have experienced breast cancer.25 However, only limited rural areas 
have trained co-ordinators to run the program. 
 
The lack of difference in overall HRQoL between regional and rural survivors may represent 
a true reflection of the non-urban experience, namely that breast cancer survivors outside 
urban areas have similar HRQoL. However, due to a decreasing population density with 
increasing remoteness,4 residents from outer regional, remote and very remote areas of 
Queensland were aggregated into one combined group termed ‘rural’ to achieve greater 
robustness of results. Therefore, potential differences in HRQoL among the most rural 
residents could not be detected in this study. 
 
Nonetheless, the results reported here provide quantitative data from a sample of 
regional/rural breast cancer survivors and suggest that a variety of factors may influence 
HRQoL status among women 12 months after diagnosis. Furthermore, using data from 
2006/2007, this study provides a current indication of the non-urban breast cancer experience. 
The population-based nature of the breast cancer sample improves generalisability of the 
results over those obtained from the clinical samples that predominate in the literature and are 
directly relevant to the Australian setting. Therefore, results are likely to be generalisable to 
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the wider population in regional/rural Australia of women diagnosed with unilateral breast 
cancer between the ages of 30 and 74 years. 
 
Based on these findings, there was little evidence to suggest differences in HRQoL among 
women residing in non-urban locations 12 months following breast cancer diagnosis. Rather, 
women diagnosed before 50 years in both regional and rural areas of Queensland fare more 
poorly than older women. In addition, the HRQoL of those who require chemotherapy or 
experience complications, who report lower upper-body function, more stress or poorer 
handling of stress, who have fewer social contacts, more unmet healthcare needs or lower 
levels of health self-efficacy is impaired. Programs effectively addressing these issues may 
prove beneficial to all breast cancer survivors, although they tend to be more challenging to 
implement in non-urban locations where they are clearly needed. 
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Table 1. Demographic and disease characteristics of the target sample and study participants 
Characteristicsa 
 
Target sample 
(n=493)  
Study 
participants 
(n=323) 
 p-value 
 n (%) n (%) 
Age (years) at diagnosis 
 <50 
 50+ 
  
 160 
 333 
 
(32.5) 
(67.5) 
 
 
 107 
 213 
 
(33.1) 
(66.9) 
 0.88 
Place of residence 
 Regional Queensland 
 Rural Queensland 
  
 300 
 193 
 
(60.9) 
(39.1) 
 
 
 202 
 121 
 
(62.5) 
(37.5) 
 
0.66 
Most extensive surgery 
 Complete local excision 
 Mastectomy/partial/radical 
  
 298 
 195 
 
(60.4) 
(39.6) 
  
 198 
 125 
 
(61.3) 
(38.7) 
 
0.83 
Number of lymph nodes removed 
 None/missing 
 1-9 
 10-19 
 20+ 
  
 61 
 171 
 188 
 73 
 
(12.4) 
(34.7) 
(38.1) 
(14.8) 
  
 44 
 106 
 126 
 47 
 
(13.6) 
(32.8) 
(39.0) 
(14.6) 
 
0.92 
Overall histological grade 
 Grade 1 
 Grade 2 
 Grade 3 
 Not available 
  
 94 
 217 
 179 
 3 
 
(19.1) 
(44.0) 
(36.3) 
(0.6) 
  
 68 
 134 
 119 
 2 
 
(21.1) 
(41.5) 
(36.8) 
(0.6) 
 
0.88 
Histological type 
 Infiltrating ductal/NOS 
 Infiltrating lobular/ductal 
 Tubular/cribriform 
 Medullary/mucinous/colloid 
 Other mixed type 
  
 401 
 42 
 7 
 6 
 37 
 
(81.3) 
(8.5) 
(1.4) 
(1.2) 
(7.5) 
  
 265 
 23 
 7 
 2 
 26 
 
(82.0) 
(7.1) 
(2.2) 
(0.6) 
(8.0) 
 
0.75 
Notes: 
(a) Information abstracted from pathology reports. 
Abbreviations: NOS: Not otherwise specified. 
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Table 2. Characteristics of regional and rural breast cancer study participants 12 months post-
diagnosis 
Characteristics 
 
Regional 
participants 
(n=202) 
 
Rural 
participants 
(n=121) 
 p-value 
 n (%) n (%) 
Age (years) at diagnosisa 
 <50 
 50+ 
  
 65 
 137 
 
(32.2) 
(67.8) 
 
 
 42 
 79 
 
(34.7) 
(65.3) 
 0.71 
Marital status 
 Married/significant relationship 
 Not married 
  
 152 
 50 
 
(75.2) 
(24.8) 
 
 
 96 
 25 
 
(79.3) 
(20.7) 
 0.42 
Occupation 
 Professional 
 White-collar worker 
 Blue-collar worker 
 Homemaker 
 Retired/student 
  
 55 
 64 
 10 
 24 
 49 
 
(27.2) 
(31.7) 
(5.0) 
(11.9) 
(24.3) 
 
 
 37 
 32 
 11 
 31 
 10 
 
(30.6) 
(26.4) 
(9.1) 
(24.6) 
(8.3) 
 <0.01 
Education level 
 Grade 10 or below 
 Grade 12, trade, TAFE, diploma 
 University or college degree or higher 
  
 98 
 72 
 32 
 
(48.5) 
(35.6) 
(15.8) 
 
 
 75 
 30 
 16 
 
(62.0) 
(24.8) 
(13.2) 
 0.06 
Private health insurance status 
 Yes 
 No 
  
 113 
 89 
 
(55.9) 
(44.1) 
  
 70 
 51 
 
(57.9) 
(42.1) 
 0.82 
Most extensive surgerya 
 Complete local excision 
 Mastectomy/partial/radical 
  
 128 
 74 
 
(63.4) 
(36.6) 
 
 
 70 
 51 
 
(57.9) 
(42.1) 
 0.35 
Adjuvant treatment 
 None 
 Chemotherapy only 
 Radiotherapy only 
 Both 
  
 41 
 14 
 69 
 78 
 
(20.3) 
(6.9) 
(34.2) 
(38.6) 
 
 
 18 
 19 
 36 
 48 
 
(14.9) 
(15.7) 
(29.8) 
(39.7) 
 0.07 
Number of lymph nodes removeda 
 None/missing 
 1-9 
 10-19 
 20+ 
 
 
  
 30 
 62 
 81 
 29 
 
(14.9) 
(30.7) 
(40.1) 
(14.4) 
 
 
 14 
 44 
 45 
 18 
 
(11.6) 
(36.4) 
(37.2) 
(14.9) 
 0.68 
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Overall histological gradea 
 Grade 1 
 Grade 2 
 Grade 3 
 Not available 
  
 45 
 80 
 75 
 2 
 
(22.3) 
(39.6) 
(37.1) 
(1.0) 
 
 
 23 
 54 
 44
 0 
 
(19.0) 
(44.6) 
(36.4) 
(0.0) 
 0.43 
Histological typea 
 Infiltrating ductal/NOS 
 Infiltrating lobular/ductal 
 Tubular/cribriform 
 Medullary/mucinous/colloid 
 Other/mixed type 
  
 165 
 16 
 4 
 1 
 16 
 
(81.7) 
(7.9) 
(2.0) 
(0.5) 
(7.9) 
  
 100 
 7 
 3 
 1 
 10 
 
(82.6) 
(5.8) 
(2.5) 
(0.8) 
(8.3) 
 0.95 
Participated in a breast cancer programb 
 Yes 
 No 
  
 65 
 137 
 
(32.2) 
(67.8) 
 
 
 25 
 96 
 
(20.7) 
(79.3) 
 0.03 
Notes: 
(a) Information abstracted from pathology reports. 
(b) A breast cancer program includes any support program specifically designed for breast cancer survivors. 
Abbreviations: NOS: Not otherwise specified. 
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Table 3. Adjusted mean HRQoL scores 12 months post-diagnosis among i) regional and rural breast cancer survivors and ii) younger (<50 years) 
and older (50+ years) regional/rural breast cancer survivors 
Health-related quality of life 
Regionala 
 
Rurala 
 
Regional/rural women 
aged <50 yearsb 
 
Regional/rural women 
aged 50+ yearsb 
mean 95% CI  mean 95% CI sign.c mean 95% CI  mean 95% CI sign.c 
Physical well-being (0-28) 22.7 22.0, 23.4  23.2 22.3, 24.1   21.4 20.5, 22.4  23.6 22.9, 24.3    * 
Social well-being (0-28) 22.4 21.6, 23.2  22.9 21.9, 23.9   21.4 20.4, 22.5  23.2 22.4, 23.9    * 
Emotional well-being (0-24) 19.4 18.8, 20.0  19.2 18.5, 20.0   17.7 16.9, 18.4  20.2 19.6, 20.7    * 
Functional well-being (0-28) 21.7 20.9, 22.5  21.9 20.9, 22.9   20.1 19.1, 21.1  22.6 21.9, 23.4    * 
Breast well-being (0-52) 37.1 36.0, 38.3  37.1 35.6, 38.6   33.2 31.6, 34.7  39.1 37.9, 40.2    * 
FACT-G (0-108) 86.1 83.9, 88.3  87.6 84.7, 90.4   81.0 78.1, 84.0  89.5 87.4, 91.6    * 
FACT-B+4 (0-160) 122.9 119.8, 126.0  123.7 119.7, 127.8   113.5 109.3, 117.8  128.2 125.1, 131.2    * 
Notes: 
(a) Adjusted for age. 
(b) Adjusted for place of residence (regional, rural). 
(c) Significance:  Clinically meaningful difference between groups;  no clinically meaningful difference between groups; * p<0.05 
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Table 4. Multivariable associations of HRQoL (FACT-B+4) 12 months post-diagnosis among 
regional/rural breast cancer survivors 
Characteristics 
 FACT-B+4a 
 n Mean (95% CI) p-value 
Place of residence 
 Regional Queensland 
 Rural Queensland  
 
 198 
 118 
 
122.3 
124.8 
 
(120.3, 124.3) 
(122.2, 127.4) 
0.14 
Age (years) at diagnosis 
 <50 
 50+  
 
 107 
 209 
 
120.3 
124.7 
 
(117.3, 123.3) 
(122.6, 126.7) 
0.03 
Adjuvant treatment 
 Both 
 Chemotherapy only 
 Radiotherapy only 
 None  
 
 125 
 33 
 103 
 55 
 
123.4 
114.7 
125.5 
123.4 
 
(120.7, 126.2) 
(109.7, 119.7) 
(122.7, 128.4) 
(119.4, 127.5) 
<0.01 
Number of complicationsb 
 None 
 One 
 Two 
 Three or four  
 
 129 
 120 
 56 
 11 
 
126.6 
121.5 
119.3 
122.0 
 
(123.9, 129.2) 
(118.9, 124.1) 
(115.5, 123.2) 
(113.4, 130.6) 
0.02 
Upper-body function 
 Poor function (11+) 
 Good function (<11) 
 Missing  
 
 160 
 141 
 15 
 
116.9 
130.5 
122.0 
 
(114.6, 119.2) 
(128.1, 133.0) 
(114.6, 129.4) 
<0.001 
Amount of stress 
 Very little 
 Some 
 A moderate amount 
 A lot  
 
 76 
 102 
 77 
 61 
 
128.6 
125.3 
119.8 
117.4 
 
(124.7, 132.5) 
(122.4, 128.1) 
(116.4, 123.2) 
(113.4, 121.4) 
0.001 
Perceived handling of stress 
 Not well at all 
 Not well 
 Fairly well 
 Very well  
 
 11 
 25 
 177 
 103 
 
106.9 
116.0 
123.2 
126.7 
 
(97.8, 115.9) 
(109.8, 122.1) 
(121.0, 125.5) 
(123.3, 130.1) 
0.001 
Social Networks Index 
 Socially isolated 
 Moderately isolated 
 Moderately integrated 
 Socially integrated 
  
 
 45 
 148 
 83 
 40 
 
118.7 
123.2 
123.8 
127.2 
 
(114.4, 123.0) 
(120.9, 125.5) 
(120.7, 126.9) 
(122.8, 131.7) 
0.06 
18 
Social-emotional support 
 No confidante 
 Communicate on a monthly basis or less 
 Communicate on a weekly basis or more  
 
 23 
 32 
 261 
 
113.5 
125.6 
123.8 
 
(107.5, 119.6) 
(120.6, 130.5) 
(122.1, 125.5) 
<0.01 
Healthcare services needs 
 Low need (<50) 
 Moderate to high need (>50)  
 
 291 
 25 
 
124.6 
107.0 
 
(123.0, 126.2) 
(100.9, 113.1) 
<0.001 
Overall health self-efficacy 
 Not at all to somewhat confident 
 Mostly to completely confident  
 
 113 
 203 
 
116.8 
126.8 
 
(113.8, 119.8) 
(124.7, 128.9) 
<0.001 
Notes: 
(a) Means and 95% CIs are mutually adjusted for all variables in the model; R2=0.66. 
(b) Complications include wound infection, other infection, skin reaction, seroma. 
 
